Create a free QxMD account to receive personalized paper recommendations, relevant to your practice.

JOURNAL ARTICLE

Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial

Marcus Maurer, Andrea Schütz, Karsten Weller, Nicole Schoepke, Adriane Peveling-Oberhag, Petra Staubach, Sabine Müller, Thilo Jakob, Martin Metz

Journal of Allergy and Clinical Immunology 2017, 140 (3): 870-873.e5

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Mary S Bradley, Janice Canvin, Abdelkader Rahmaoui, Panayiotis Georgiou, Oral Alpan, Sheldon Spector, Karin Rosén Journal of Investigative Dermatology 2015, 135 (1): 67-75

Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study. J Boyle, P Marks, J R Gibson Journal of International Medical Research 1989, 17 Suppl 2: 9B-13B

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy. Robert A Wood, Jennifer S Kim, Robert Lindblad, Kari Nadeau, Alice K Henning, Peter Dawson, Marshall Plaut, Hugh A Sampson Journal of Allergy and Clinical Immunology 2016, 137 (4): 1103-1110.e11

Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial. P Staubach, M Metz, N Chapman-Rothe, C Sieder, M Bräutigam, J Canvin, M Maurer Allergy 2016, 71 (8): 1135-44

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. Bob Lanier, Tracy Bridges, Marek Kulus, Angel Fowler Taylor, Indrias Berhane, Carlos Fernandez Vidaurre Journal of Allergy and Clinical Immunology 2009, 124 (6): 1210-6

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. Sarbjit Saini, Karin E Rosen, Hsin-Ju Hsieh, Dennis A Wong, Edward Conner, Allen Kaplan, Sheldon Spector, Marcus Maurer Journal of Allergy and Clinical Immunology 2011, 128 (3): 567-73.e1

Omalizumab for asthma in adults and children. Rebecca Normansell, Samantha Walker, Stephen J Milan, E Haydn Walters, Parameswaran Nair Cochrane Database of Systematic Reviews 2014 January 13, (1): CD003559

Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. Nicola A Hanania, Oral Alpan, Daniel L Hamilos, John J Condemi, Irmarie Reyes-Rivera, Jin Zhu, Karin E Rosen, Mark D Eisner, Dennis A Wong, William Busse Annals of Internal Medicine 2011 May 3, 154 (9): 573-82

Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria. Michihiro Hide, Hae-Sim Park, Atsuyuki Igarashi, Young-Min Ye, Tae-Bum Kim, Akiko Yagami, Jooyoung Roh, Jae-Hyun Lee, Yuko Chinuki, Sang Woong Youn, Soo-Keol Lee, Naoko Inomata, Jeong-Hee Choi, Atsushi Fukunaga, Junyi Wang, Soichiro Matsushima, Steve Greenberg, Sam Khalil Journal of Dermatological Science 2017, 87 (1): 70-78

Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review. Diana C Carrillo, Mario Sanchez Borges, Elizabeth García, Eduardo Egea, Carlos D Serrano World Allergy Organization Journal 2014, 7 (1): 72

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips